About the report
Austria is home to a highly innovative and internationally connected oncology ecosystem. From advanced clinical infrastructure and leading academic research to emerging startups and digital health technologies – the country’s cancer innovation landscape is gaining momentum.

The “Austrian Oncology Innovation Report 2025” is the first comprehensive publication that maps and showcases this unique innovation ecosystem. It offers insights across the full spectrum of oncology innovation with a special focus on startups, scaleups and spinoffs, corporate innovation, ecosystem hubs and supporters as well as general trends and developments.

Our mission is to position Austria as a global leader in oncology innovation by raising international awareness, supporting market entry decisions for international stakeholders, and fostering cross-sector collaboration among innovators, industry, and healthcare providers. By highlighting current innovative solutions and the future potential of cancer care, we ultimately aim to demonstrate the transformative power of innovation to the medical community and to practicing oncologists.

Format & Distribution
Format: Independent report (~25 pages, A4)
Language: English (German optional)
Availability: Digital in PDF (Print optional)
Regional Distribution Focus: Austria (Tier 1), Europe (Tier 2), US & China (Tier 3)
Distribution Period: 2025 / 2026
Distribution:

• • Through strategic partner networks, newsletters & digital media

  • Direct outreach to key stakeholders: oncology & health networks, clusters, associations & NGOs, research centers, hospitals, corporates and pharma, patient organisations, innovation hubs, ministries, public & EU agencies

  • Media partners (medical & innovation media outlets and communities)

  • National and international oncology & health innovation conferences

Target Audience

• • Pharma, biotech & health companies

  • Hospitals, clinics, and cancer centers

  • Professional association of medical oncologists

  • Policymakers & health administrators

  • EU agencies & cluster organisations

  • International investors, VCs & business angels

  • Health innovation startups & scale-ups

  • Academic & research institutions

  • Innovation hubs and networks

Timeline
Report release (digital): Q4 2025

Support the Initiative
As a partner, your organisation will gain high-level visibility among a focused national and international audience, positioning you as a key enabler in advancing innovation across health, oncology, and medical technology.
Together, we can drive impactful progress, empower startups, and accelerate the development of cutting-edge solutions that improve lives worldwide.